Reuters logo
3 个月前
BRIEF-Nabriva Therapeutics to present data at ASM microbe supporting ongoing phase 3 clinical development program for lefamulin
2017年6月2日 / 上午11点27分 / 3 个月前

BRIEF-Nabriva Therapeutics to present data at ASM microbe supporting ongoing phase 3 clinical development program for lefamulin

June 2 (Reuters) - Nabriva Therapeutics Ag

* Nabriva Therapeutics to present data at ASM microbe supporting ongoing phase 3 clinical development program for lefamulin Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below